Table 4.

Long-term outcome.

Character	NO (%) 410 (100%) Or Median(range)
Late (>6 months post-Kasai) complications Cholangitis(Early and/or late) Early cholangitis Late cholangitis Cholangitis within 2 years Chest infection PHN(early and/or late) Late PHN GO varices ± GIT bleeding HPS Incisional hernia Intestinal obstruction Encephalopathy Ascites	256 (62.4%) 175 (42.7%) 108 (26.3%) 99 (24.1%) 161 (39.3%) 15 (3.7%) 239 (58.3%) 193 (47.1%) 163 (39.8%) 34 (8.3%) 3 (0.7%) 7 (1.7%) 43 (10.5%) 186 (45.4%)
CDS of late complications II III V	7 (1.7%) 19 (4.6%) 230 (56.1%)
LT after Kasai Onset of LT(months) (Median(range))	19 (4.6%) 21.5(5–118)
Late patient(>6 months) mortality Mortality in non transplanted cases Main causes Liver failure Sepsis GIT bleeding HPS Post transplant mortality Main causes Post transplant Sepsis Chronic rejection PVT HAT	240 (58.5%) 230 (56.1%) 149 (36.3%) 49 (12%) 18 (4.4%) 14 (3.4%) 10 (2.4%) 5 (1.2%) 3 (0.7%) 1 (0.2%) 1 (0.2%)
Long-term NLS NLS (months) (Median(range)) 1-year NLS 3-year NLS 5-year NLS 10-year NLS 15-year NLS 20-year NLS Long-term overall survival Overall survival (months) (Median(range)) 1-year overall survival 3-year overall survival 5-year overall survival 10-year overall survival 15-year overall survival 20-year overall survival	91 (22.2%) 40(0.2–243) 315 (76.8%) 236 (57.6%) 204 (49.8%) 152 (37.1%) 101 (24.6%) 91 (22.2%) 100 (24.4%) 44(0.2–243) 318 (77.6%) 244 (59.5%) 211 (51.5%) 161 (39.3%) 110 (26.8%) 100 (24.4%)

PHN: Portal hypertension, GO: Gastro-esophageal, GIT: Gastrointestinal system, HPS: Hepatopulmonary syndrome, CDS: Calvien Dindo system, LT: Liver transplantation, PVT: Portal vein thrombosis, HAT: Hepatic artery thrombosis, NLs: Native liver survival.